The data shows that variants predicted to affect microexons are predominant in the 85% of autistic individuals that lack a genetic link.
Colossal Biosciences on October 14, 2026 unveiled GenoMorph, an artificial-intelligence platform developed to identify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results